Enlivex Therapeutics Financials Indicate Net Loss

Enlivex (ENLV) has released an update.

Enlivex Therapeutics Ltd. reports its financial status, showing a total asset decrease from $36,831 thousand to $31,902 thousand between December 31, 2023, and June 30, 2024. The balance sheet reveals a drop in current assets and an accumulated deficit increase, reflecting a challenging fiscal period with a net loss of $7,236 thousand for the six months ended June 30, 2024. These unaudited figures highlight Enlivex’s financial movements and potential concerns for investors.

For further insights into ENLV stock, check out TipRanks’ Stock Analysis page.